CUBE vs IBO
CubeSmart (CUBE) versus Impact BioMedical, Inc. (IBO) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. IBO currently screens at market cap $7.6M.
Not investment advice. Open the CUBE and IBO stock pages for the full models.
Not investment advice.